10/23/2026
Specialty pharmacy doesn't end when a prescription leaves your organization. π
According to Brittany Ulrich, payer restrictions, limited-distribution drugs, and network requirements often force specialty prescriptions outside a health system's pharmacy, creating visibility gaps into whether treatment was started, how patients are progressing, and whether they remain adherent to therapy.
When pharmacies lose access to this information, care coordination becomes more difficult, making it harder to track outcomes and support patients throughout their treatment journey.
π Learn more: https://www.mckesson.com/health-systems/prescribed-perspectives/keeping-care-connected-closing-visibility-gaps-in-specialty-pharmacy/
Specialty prescriptions may leave the health system, but critical patient insights don't have to. Learn how McKesson helps health systems achieve more for care continuity, visibility gaps, and 340B value despite 340B contract pharmacy restrictions.